Analyst consensus rating
Sana Biotechnology Analyst Rating: none
Direct answer
Sana Biotechnology's consensus rating is none.
7 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.43.
Forecast evidence checked September 17, 2026.
Get free Sana Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.92
- Average price target
- $8.43
- High price target
- $12.00
- Low price target
- $6.00
- Low target gap
- +105.5%
- Target upside
- +188.6%
- High target gap
- +311%
- Target range width
- 205.5%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- September 17, 2026
- Valid through
- September 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Sana Biotechnology?
Sana Biotechnology has a verified none consensus. The same dataset has an average price target of $8.43.
How far are Sana Biotechnology's low and high targets from the recorded price?
The low target implies +105.5%, while the high target implies +311%.
How many analysts are included in Sana Biotechnology's consensus?
The verified consensus includes 7 analysts.
How is Sana Biotechnology's target upside or downside calculated?
The average target of $8.43 is divided by the recorded price of $2.92, then one is subtracted to produce +188.6%. This does not guarantee a future return.
When was Sana Biotechnology's analyst forecast verified?
The data was verified on 2026-09-17. The dataset is valid through 2026-09-24.